BR112015000475A2 - métodos de indução de anestesia - Google Patents
métodos de indução de anestesiaInfo
- Publication number
- BR112015000475A2 BR112015000475A2 BR112015000475A BR112015000475A BR112015000475A2 BR 112015000475 A2 BR112015000475 A2 BR 112015000475A2 BR 112015000475 A BR112015000475 A BR 112015000475A BR 112015000475 A BR112015000475 A BR 112015000475A BR 112015000475 A2 BR112015000475 A2 BR 112015000475A2
- Authority
- BR
- Brazil
- Prior art keywords
- anesthetic
- provides methods
- methods
- selectivity
- determining
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 10
- 206010002091 Anaesthesia Diseases 0.000 title abstract 4
- 230000037005 anaesthesia Effects 0.000 title abstract 4
- 230000006698 induction Effects 0.000 title 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- 230000001939 inductive effect Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002685 pulmonary effect Effects 0.000 abstract 2
- 230000037361 pathway Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
- A61D7/04—Devices for anaesthetising animals by gases or vapours; Inhaling devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/01—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes specially adapted for anaesthetising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
abstract of the disclosure [0234] the present invention provides methods for determining the selectivity of an anesthetic for an anesthetic-sensitive receptor by determining the molar water solubility of the anesthetic. the invention further provides methods for modulating the selectivity of an anesthetic for an anesthetic-sensitive receptor by altering or modifying the anesthetic to have higher or lower water solubility. the invention further provides methods of inducing anesthesia in a subject by administering via the respiratory pathways (e.g., via inhalational or pulmonary delivery) an effective amount of an anesthetic compound identified according to the present methods. tradução do resumo resumo patente de invenção: "métodos de indução de anestesia". a presente invenção proporciona métodos para determinar a seletividade de um anestésico por um receptor sensível ao anestésico através de determinação da solubilidade em água molar do anestésico. a invenção proporciona ainda métodos para modulação da seletividade de um anestésico por um receptor sensível ao anestésico ao alterar ou modificar o anestésico para ter maior ou menor solubilidade em água. a invenção proporciona ainda métodos para induzir à anestesia em um indivíduo por meio de administração, através das vias respiratórias (por exemplo, através de distribuição por inalação ou pulmonar) de uma quantidade eficaz de um composto anestésico identificado de acordo com os presentes métodos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261670098P | 2012-07-10 | 2012-07-10 | |
US201261681747P | 2012-08-10 | 2012-08-10 | |
PCT/US2013/031668 WO2014011235A1 (en) | 2012-07-10 | 2013-03-14 | Methods of inducing anesthesia |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015000475A2 true BR112015000475A2 (pt) | 2017-08-08 |
Family
ID=49914505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015000475A BR112015000475A2 (pt) | 2012-07-10 | 2013-03-14 | métodos de indução de anestesia |
Country Status (12)
Country | Link |
---|---|
US (6) | US20140018414A1 (pt) |
EP (3) | EP4032533A1 (pt) |
JP (4) | JP2015525757A (pt) |
KR (4) | KR20230078698A (pt) |
CN (3) | CN116585292A (pt) |
AU (4) | AU2013289204B2 (pt) |
BR (1) | BR112015000475A2 (pt) |
CA (2) | CA2878686A1 (pt) |
GB (1) | GB2507936A (pt) |
IL (3) | IL301618A (pt) |
IN (1) | IN2015KN00299A (pt) |
WO (2) | WO2014011235A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107898791A (zh) | 2010-06-03 | 2018-04-13 | 药品循环有限责任公司 | 布鲁顿酪氨酸激酶(btk)抑制剂的应用 |
EP4032533A1 (en) | 2012-07-10 | 2022-07-27 | The Regents of The University of California | Methods of inducing anesthesia |
KR20150032340A (ko) | 2012-07-24 | 2015-03-25 | 파마시클릭스, 인코포레이티드 | 브루톤 티로신 키나제(btk)의 억제제에 대한 내성과 관련된 돌연변이 |
US9885086B2 (en) | 2014-03-20 | 2018-02-06 | Pharmacyclics Llc | Phospholipase C gamma 2 and resistance associated mutations |
WO2015187918A2 (en) * | 2014-06-05 | 2015-12-10 | The Regents Of The University Of California | Halogenated ether compounds and methods of inducing anesthesia |
EP3040061A1 (en) * | 2015-01-02 | 2016-07-06 | Fitesa Germany GmbH | Nonwoven fabric and process for forming the same |
CN105168202A (zh) * | 2015-10-09 | 2015-12-23 | 烟台毓璜顶医院 | 一种吸入式复合麻醉维持剂 |
US10467138B2 (en) * | 2015-12-28 | 2019-11-05 | Advanced Micro Devices, Inc. | Caching policies for processing units on multiple sockets |
WO2020050249A1 (ja) * | 2018-09-03 | 2020-03-12 | 東ソ-株式会社 | ヘキサフルオロプロピレンオキシドへのアルデヒド類付加体、トリフルオロピルビン酸フルオリドダイマーの製造方法およびパーフルオロ(2,4-ジメチル-2-フルオロホルミル-1,3-ジオキソラン)の製造方法 |
CN112638891A (zh) | 2018-09-03 | 2021-04-09 | 东曹株式会社 | 六氟环氧丙烷的醛类加成物、三氟丙酮酰氟二聚体的制造方法及全氟(2,4-二甲基-2-氟甲酰基-1,3-二氧戊环)的制造方法 |
JP7307586B2 (ja) * | 2019-04-26 | 2023-07-12 | 東ソー株式会社 | パーフルオロ(2,4-ジメチル-2-フルオロホルミル-1,3-ジオキソラン)の製造方法 |
JP7307587B2 (ja) * | 2018-09-03 | 2023-07-12 | 東ソー株式会社 | ヘキサフルオロプロピレンオキシドへのアルデヒド類付加体、およびトリフルオロピルビン酸フルオリドダイマーの製造方法 |
US11325893B2 (en) * | 2018-09-26 | 2022-05-10 | 3M Innovative Properties Company | Hydrofluoroethers and methods of using same |
KR20210102936A (ko) * | 2018-12-10 | 2021-08-20 | 헤일로 사이언스 엘엘씨 | 안정적인 마취제 제제 및 관련 복용량 형태 |
WO2021146371A1 (en) * | 2020-01-17 | 2021-07-22 | Expanesthetics, Inc. | Method of inducing analgesia using a halogenated alcohol |
WO2022204459A1 (en) * | 2021-03-25 | 2022-09-29 | University Of Florida Research Foundation, Inc. | Methods and compositions for treatment of low circulating testosterone conditions |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1069639B (de) | 1959-11-26 | Salline Ludwigshalle A.G., Bad Wimpfen | Verfahren zur Herstellung von cyclischen Perfluorkohlcnstoffäthern mit 5- oder 6-gliedrigen Ringen | |
US2594272A (en) | 1948-09-10 | 1952-04-29 | Minnesota Mining & Mfg | Cyclic fluoroalkylene oxide compounds |
GB718318A (en) | 1952-06-24 | 1954-11-10 | Minnesota Mining & Mfg | Improvements in or relating to process of preparing cyclic fluoroalkylene oxide compounds and the cyclic fluoroalkylene oxide compounds resulting from said process |
ES251349A1 (es) | 1958-08-21 | 1960-01-16 | Ludwigshalle Saline | PROCEDIMIENTO PARA LA OBTENCIoN DE ÉTERES PERFLUOROCARBoNICOS CiCLICOS CON ANILLOS DE 5 o 6 MIEMBROS |
US3187748A (en) | 1963-04-29 | 1965-06-08 | Merck And Company Inc | Inhalation-actuated aerosol device |
US3314850A (en) * | 1965-09-17 | 1967-04-18 | Allied Chem | 2, 2-bis(trifluoromethyl)-1, 3-dioxolane as inhalation anesthetic |
US3476860A (en) | 1966-12-08 | 1969-11-04 | Air Reduction | Halomethyl fluoroisopropyl ethers as anesthetic agents |
US3565070A (en) | 1969-02-28 | 1971-02-23 | Riker Laboratories Inc | Inhalation actuable aerosol dispenser |
NL7103057A (pt) | 1970-03-12 | 1971-09-14 | ||
US3683092A (en) | 1970-07-31 | 1972-08-08 | Baxter Laboratories Inc | Method of anesthesia |
JPS4812742B1 (pt) | 1970-08-17 | 1973-04-23 | ||
JPS4927588B1 (pt) | 1970-10-14 | 1974-07-18 | ||
US3749791A (en) * | 1971-07-15 | 1973-07-31 | Airco Inc | Fluorine or chlorine-substituted 2,2-bis(trifluoromethyl)-1,3-dioxolane anesthetics |
NO134730L (pt) | 1971-07-19 | 1900-01-01 | ||
US3749793A (en) * | 1971-08-02 | 1973-07-31 | Airco Inc | Ether compounds as inhalation anesthetics |
US3870797A (en) | 1971-08-09 | 1975-03-11 | Grace W R & Co | Anesthetic halogenated cyclobutanes |
NL7115894A (pt) * | 1971-08-09 | 1973-02-13 | ||
US3954893A (en) | 1971-08-09 | 1976-05-04 | W. R. Grace & Co. | New halogenated cyclobutanes |
NL7115893A (pt) | 1971-08-09 | 1973-02-13 | ||
US3749794A (en) * | 1971-08-13 | 1973-07-31 | Airco Inc | Ether compounds as inhalation anesthetics |
US3897502A (en) | 1971-10-22 | 1975-07-29 | Airco Inc | Process for making fluorinated ethers |
GB1413285A (en) | 1971-11-25 | 1975-11-12 | Bespak Industries Ltd | Aerosol devices |
US4060532A (en) | 1972-03-15 | 1977-11-29 | Ici United States Inc. | Halogenated dioxolane tranquilizers |
GB1448981A (en) * | 1972-06-09 | 1976-09-08 | Ici Ltd | Fluorinated dioxan derivatives |
US4017519A (en) | 1973-04-05 | 1977-04-12 | Airco, Inc. | Fluoro dioxolane anesthetic compounds |
US4113435A (en) | 1973-07-16 | 1978-09-12 | Massachusetts Institute Of Technology | Cryogenically controlled direct fluorination apparatus |
JPS514994B2 (pt) | 1974-01-31 | 1976-02-16 | ||
DE2520962A1 (de) | 1975-05-12 | 1976-12-02 | Hoechst Ag | 1.2.2.2-tetrafluoraethyl-fluormethylaether und verfahren zu dessen herstellung |
DE2524956A1 (de) | 1975-06-05 | 1976-12-16 | Hoechst Ag | 2-hydro-perfluor-n-propyl-fluormethylaether und verfahren zu seiner herstellung |
DE2604350A1 (de) * | 1975-09-22 | 1977-03-24 | Stanford Research Inst | Anaesthetisch wirksame halogen-substituierte 2,2-difluor-1,3-dioxolane und verfahren zur inhalations-anaesthesie |
JPS5145594B2 (pt) | 1975-12-10 | 1976-12-04 | ||
JPS5325552A (en) | 1976-08-21 | 1978-03-09 | Agency Of Ind Science & Technol | Preparation of perfluorotetrahydrofuran derivatives |
JPS53124259A (en) | 1977-04-06 | 1978-10-30 | Agency Of Ind Science & Technol | Preparation of perfluoro (3-methyltetrahydrofran) |
JPS5551084A (en) | 1978-10-11 | 1980-04-14 | Agency Of Ind Science & Technol | Purification of perfluoro(2-alkyltetrahydropyran) |
DE2906447A1 (de) * | 1979-02-20 | 1980-09-04 | Hoechst Ag | Verfahren zur herstellung von 4,5- perfluor-1,3-dioxolanen und neue verbindungen dieser klasse |
US4346246A (en) | 1979-03-12 | 1982-08-24 | Airco, Inc. | Process for adjusting the halogen content of halogenated aliphatic ethers |
US4334105A (en) | 1979-04-25 | 1982-06-08 | Airco, Inc. | Method for the dehalogenation of ethers |
JPS56142877A (en) | 1980-07-23 | 1981-11-07 | Agency Of Ind Science & Technol | Manufacture of perfluoro (3-methyltetrahydrofuran) |
US4533741A (en) | 1981-11-19 | 1985-08-06 | E. I. Dupont De Nemours And Company | 4,5-Dichloro-2,2,4,5,-tetrafluoro-1,3-dioxolane |
US4648393A (en) | 1984-11-02 | 1987-03-10 | Ackrad Laboratories, Inc. | Breath activated medication spray |
US4592348A (en) | 1984-12-17 | 1986-06-03 | Waters Iv William C | Aerosol inhaler |
US4803978A (en) | 1985-08-09 | 1989-02-14 | Johnson Iv John J | Apparatus for actuating an inhaler |
EP0271272B1 (en) | 1986-12-01 | 1992-04-15 | Tokuyama Corporation | Process for preparation of perfluoro organic compounds |
US4762856A (en) | 1987-02-02 | 1988-08-09 | Boc, Inc. | Anesthetic composition and method of using the same |
US4896832A (en) | 1987-09-07 | 1990-01-30 | Bespak Plc | Dispensing apparatus for metered quantities of pressurised fluid |
DE3735467A1 (de) | 1987-10-20 | 1989-05-03 | Bayer Ag | Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme |
JP2606875B2 (ja) | 1988-03-31 | 1997-05-07 | 株式会社トクヤマ | 有機化合物のフッ素化方法 |
IT1230873B (it) | 1989-06-20 | 1991-11-08 | Ausimont Srl | Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti. |
US5026801A (en) | 1989-09-18 | 1991-06-25 | E. I. Du Pont De Nemours And Company | Polyhalodihydrodioxins and polyhalodioxoles |
CA2071201A1 (en) | 1989-12-11 | 1991-06-12 | Ronald J. Mckinney | Partially fluorinated compounds and polymers |
DE4004494A1 (de) | 1990-02-14 | 1991-08-22 | Bayer Ag | Verfahren zur herstellung von gesaettigten, fluorhaltigen und chlorfreien kohlenwasserstoffen |
WO1991013846A1 (en) | 1990-03-05 | 1991-09-19 | E.I. Du Pont De Nemours And Company | 1,1,2,2,3,3-hexafluorocyclopentane and use thereof in compositions and processes for cleaning |
IT1249208B (it) * | 1990-06-07 | 1995-02-20 | Ausimont Srl | Processo per la preparazione di 1,3-diossolani alogenati e nuovi prodotti ottenuti |
IT1244708B (it) | 1991-02-07 | 1994-08-08 | Ausimont Spa | Processo di dealogenazione di 1,3-diossolani |
US5268122A (en) | 1991-08-28 | 1993-12-07 | E. I. Du Pont De Nemours And Company | Gem-dihydropolyfluoroalkanes and monohydropolyfluoroalkenes, processes for their production, and use of gem-dihydropolyfluoroalkanes in cleaning compositions |
WO1994007829A1 (en) | 1992-09-30 | 1994-04-14 | Nippon Zeon Co., Ltd. | Process for producing fluorinated saturated hydrocarbon |
US5488189A (en) | 1993-12-14 | 1996-01-30 | E. I. Du Pont De Nemours And Company | Process for fluorinated propanes and pentanes |
IT1269517B (it) | 1994-05-19 | 1997-04-01 | Ausimont Spa | Polimeri e copolimeri fluorurati contenenti strutture cicliche |
JP3818395B2 (ja) | 1994-06-30 | 2006-09-06 | 独立行政法人産業技術総合研究所 | 弗素化アルケン誘導体及び弗素化アルカン誘導体の製造方法 |
JP3729281B2 (ja) | 1994-11-24 | 2005-12-21 | 独立行政法人産業技術総合研究所 | 弗素化アルケン誘導体および弗素化アルカン誘導体の製造方法 |
JPH10316597A (ja) | 1997-05-15 | 1998-12-02 | Agency Of Ind Science & Technol | 弗素化飽和炭化水素 |
JP4538953B2 (ja) | 1997-12-26 | 2010-09-08 | 日本ゼオン株式会社 | −ch2−chf−基を有する化合物の製造方法 |
IT1298257B1 (it) | 1998-02-17 | 1999-12-20 | Ausimont Spa | Perfluorodiossoli |
JP4186253B2 (ja) | 1998-03-31 | 2008-11-26 | 日本ゼオン株式会社 | フッ素化飽和炭化水素の製造方法 |
JP4120043B2 (ja) | 1998-04-01 | 2008-07-16 | 日本ゼオン株式会社 | フッ素化不飽和炭化水素の製造方法 |
JP3072083B2 (ja) | 1998-11-04 | 2000-07-31 | 財団法人地球環境産業技術研究機構 | 含フッ素ジオキソランおよびその製造方法 |
EP0999195B1 (en) | 1998-11-05 | 2006-02-08 | Central Glass Company, Limited | Method for preparing perhalogenated five-membered cyclic compound |
JP3856076B2 (ja) | 1998-11-30 | 2006-12-13 | 日本ゼオン株式会社 | ヘプタフルオロシクロペンタンの製造方法 |
JP3794859B2 (ja) | 1999-03-01 | 2006-07-12 | セントラル硝子株式会社 | パーハロゲン化シクロペンタンの製造方法 |
JP4423414B2 (ja) | 2000-02-29 | 2010-03-03 | 独立行政法人産業技術総合研究所 | ヘプタフルオロシクロペンタンの製造方法 |
JP2001240569A (ja) | 2000-02-29 | 2001-09-04 | Nippon Zeon Co Ltd | −ch2−chf−基を有する化合物の製造方法 |
JP4306081B2 (ja) | 2000-03-07 | 2009-07-29 | 日本ゼオン株式会社 | 1,1,2,2,3,3,4−ヘプタフルオロシクロペンタンの製造方法およびその製造装置 |
JP3897081B2 (ja) | 2000-03-17 | 2007-03-22 | 日本ゼオン株式会社 | 1−クロロヘプタフルオロシクロペンテンの製造方法 |
JP4169121B2 (ja) | 2001-02-13 | 2008-10-22 | 日本ゼオン株式会社 | ヘプタフルオロシクロペンタンの製造方法 |
JP4846977B2 (ja) | 2001-10-17 | 2011-12-28 | ピラマル クリティカル ケアー インコーポレイテッド | 意識下鎮静のための薬物送達システム |
ITMI20030606A1 (it) | 2003-03-27 | 2004-09-28 | Solvay Solexis Spa | Procedimento per preparare idrofluoroeteri. |
US7067468B2 (en) | 2003-06-20 | 2006-06-27 | Degroot Richard J | Azeotrope compositions containing a fluorocyclopentane |
ITMI20071481A1 (it) | 2007-07-23 | 2009-01-24 | Milano Politecnico | Processo per la sintesi di perfluoroalchileteri |
KR20100049663A (ko) | 2007-08-27 | 2010-05-12 | 와이어쓰 엘엘씨 | 마취제-절감 효과를 달성하기 위해 nmda 길항제를 사용하는 조성물 및 방법 |
EP2459182B1 (en) | 2009-07-30 | 2017-09-06 | University of Zürich | Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event |
CN101698649B (zh) * | 2009-10-22 | 2012-03-07 | 李世系 | 一种用于麻醉的短效催眠镇静的化合物 |
EP4032533A1 (en) | 2012-07-10 | 2022-07-27 | The Regents of The University of California | Methods of inducing anesthesia |
WO2015187918A2 (en) | 2014-06-05 | 2015-12-10 | The Regents Of The University Of California | Halogenated ether compounds and methods of inducing anesthesia |
-
2013
- 2013-03-14 EP EP21215802.6A patent/EP4032533A1/en active Pending
- 2013-03-14 GB GB1404639.5A patent/GB2507936A/en not_active Withdrawn
- 2013-03-14 KR KR1020237011961A patent/KR20230078698A/ko not_active Application Discontinuation
- 2013-03-14 JP JP2015521601A patent/JP2015525757A/ja active Pending
- 2013-03-14 IL IL301618A patent/IL301618A/en unknown
- 2013-03-14 CN CN202310475740.XA patent/CN116585292A/zh active Pending
- 2013-03-14 WO PCT/US2013/031668 patent/WO2014011235A1/en active Application Filing
- 2013-03-14 CN CN201380046789.8A patent/CN104619319A/zh active Pending
- 2013-03-14 KR KR1020207018030A patent/KR20200078684A/ko active Application Filing
- 2013-03-14 CN CN201810014755.5A patent/CN108042514A/zh active Pending
- 2013-03-14 EP EP18151918.2A patent/EP3329966B1/en active Active
- 2013-03-14 KR KR1020157003612A patent/KR20150036535A/ko active Application Filing
- 2013-03-14 CA CA2878686A patent/CA2878686A1/en not_active Abandoned
- 2013-03-14 KR KR1020217036769A patent/KR20210137252A/ko not_active Application Discontinuation
- 2013-03-14 BR BR112015000475A patent/BR112015000475A2/pt not_active Application Discontinuation
- 2013-03-14 CA CA3135005A patent/CA3135005A1/en active Pending
- 2013-03-14 AU AU2013289204A patent/AU2013289204B2/en active Active
- 2013-03-14 US US13/830,907 patent/US20140018414A1/en not_active Abandoned
- 2013-03-14 EP EP13816414.0A patent/EP2872134A4/en not_active Withdrawn
- 2013-07-10 WO PCT/US2013/049985 patent/WO2014011815A2/en active Application Filing
- 2013-07-10 US US14/414,089 patent/US9381185B2/en active Active
-
2015
- 2015-01-11 IL IL236644A patent/IL236644B/en active IP Right Grant
- 2015-02-03 IN IN299KON2015 patent/IN2015KN00299A/en unknown
-
2016
- 2016-06-17 US US15/186,335 patent/US9757353B2/en active Active
-
2017
- 2017-10-19 US US15/788,034 patent/US10010525B2/en active Active
- 2017-11-02 JP JP2017213054A patent/JP6585139B2/ja active Active
-
2018
- 2018-04-27 AU AU2018202933A patent/AU2018202933A1/en not_active Abandoned
- 2018-05-22 US US15/986,656 patent/US20190000793A1/en not_active Abandoned
-
2019
- 2019-09-04 JP JP2019160900A patent/JP6916542B2/ja active Active
- 2019-12-02 AU AU2019275518A patent/AU2019275518B2/en active Active
-
2020
- 2020-08-17 IL IL276761A patent/IL276761B2/en unknown
- 2020-11-02 US US17/087,365 patent/US20220288011A9/en active Pending
-
2021
- 2021-07-09 JP JP2021114241A patent/JP7427259B2/ja active Active
-
2022
- 2022-01-27 AU AU2022200492A patent/AU2022200492A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015000475A2 (pt) | métodos de indução de anestesia | |
BR112015014567A2 (pt) | compostos de piridina-2-carboxamida substituída como inibidores da quinase reguladora do sinal de apoptose | |
BR112012017800A2 (pt) | composição hospedeira/hóspede de entrega de sedativo ou anestésico, composição anestésica ou sedativa, composição anestésica ou de sedação, método de indução ou manutenção por administração de bolo intermitente ou infusão, anestesia ou sedação em um indivíduo, 5 uso de anestésico esteroide neuroativo e clodextrina ou uma forma modificada dos mesmos na fabricação de um medicamento para induzir anestesia em um indivíduo e método de indução ou manutenção por administração de bolo intermitente ou infusão, sedação em 10 um indivíduo humano | |
EA201400591A1 (ru) | Ингалятор | |
MX2013012526A (es) | Métodos para tratar la enfermedad de alzheimer, enfermedad de huntington, autismo u otros trastornos. | |
WO2012094636A3 (en) | Chemosensory receptor ligand-based therapies | |
NZ630649A (en) | Vaccine against rsv | |
BR112015028964A2 (pt) | composição de suspensão, e, método para tratar uma doença ou um distúrbio pulmonar | |
BR112015028452A2 (pt) | agonistas do receptor somastatina subtipo 4 (sstr4) | |
EA201590933A1 (ru) | Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования | |
BR112015021596A2 (pt) | moduladores de gpr120 de ácido oxabiciclo[2.2.2] | |
BR112014004726A2 (pt) | combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2 | |
BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
BR112014026305A2 (pt) | derivado de quinazolidinadiona | |
BR112013024973A2 (pt) | prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2 | |
BR112014031091A2 (pt) | Derivados de piperidina para agonista de gpr119 | |
BR112014009225A2 (pt) | uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes | |
BR112013022213A2 (pt) | administração parenteral de tapentadol | |
BR112014027884A2 (pt) | combinações farmacêuticas para tratamento de distúrbios metabólicos | |
BR112014012459A2 (pt) | 2h-indazóis como antagonistas do receptor de ep2 | |
BR112017013999A2 (pt) | ?composição derivada de uma bifidobactéria? | |
BR112015021990A2 (pt) | moduladores de gpr120 de ácido biciclo [2.2.1] | |
UY32435A (es) | 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona útil en el tratamiento de enfermedades pulmonares | |
BR112015007641A8 (pt) | Tratamento da doença de alzheimer branda e moderada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |